Skip to main content
. 2022 Dec 29;12:22570. doi: 10.1038/s41598-022-26943-z

Figure 6.

Figure 6

Levels of TGF-β in serum from COVID-19 patients and Healthy control subjects (HCs). (A) Serum TGF-β was measured in 28 COVID-19 patients (14 moderate and 14 severe) and 6 HCs. (B) Release of TGF-β into the media of MDSCs isolated from fresh peripheral blood cells of patients co-cultured with autologous MDPs from the same patients and homologous PBMCs from HCs in the presence of PHA for 3 days. All values are presented as the mean and 5–95% percentile and comparisons made between control and patient groups were performed using ANOVA followed by a Tukey's test. *P < 0.01, **P < 0.001, ***P < 0.0001 and ****P < 0.0001. HC healthy control, M moderate, S severe, MDP MDSC depleted PBMC, MHC male healthy control, MMP moderate male patients, SMP severe male patients, FHC female healthy control, MFP moderate female patients, SFP severe female patients.